Isdinceutics

Glicoisdin® 15 Moderate

Exfoliating cream with 6.1% free glycolic acid formulated for combination or oily skin

RRP  $119.00

Facial cream formulated with 15% partially neutralised glycolic acid (equivalent to 6.1% free glycolic) that exfoliates the surface of the skin, helping to smooth its texture and promote the skin renewal process.

Its Aloe Vera content provides a moisturising action and helps reduce irritation

  • Reduces wrinkles, fine lines and blemishes *
  • Improves elasticity and luminosity
  • Helps stimulate collagen formation *
  • Unifies skin tone
  • Promotes the process of skin renewal
  • Hydrates and retextures
  • Benefits
  • How to Use
  • Clinical Results

Reveal your best skin yet

A rejuvenating cream formula designed for combination or oily and acne-prone skin, pairing the exfoliating power of glycolic acid with the nourishing properties of aloe vera.

Dual-action formula

Help exfoliate while soothing your skin with Glicoisdin® 15 Moderate.

Exfoliates

Stimulates the skin’s natural renewal process to promote skin turnover.

Renews

Significantly diminishes the appearance of dark spots.

Illuminates

Visibly refreshes dull-looking skin, revealing a radiant complexion.

How to Apply

Apply daily to the face. During the first week of use, apply small amounts on alternate days, and continuously during the following weeks. Use of glycolic peel can cause irritation. To decrease the potential for irritation, a lower concentration product can be used and once your skin becomes accustomed, a higher concentration glycolic acid can be used. Apply preferably at night. Its daily use requires the simultaneous use of a facial sunscreen.

After 4 weeks of applying Glicoisdin® Gels¹, users reported²:

100%

Skin is renewed

100%

Skin appears more uniform

96%

Skin texture improved

87%

Wrinkles and fine lines reduced


¹Users switched from Glicoisdin® Moderate Gel to Glicoisdin® Intense Gel after 2 weeks due to positive skin acceptance. ²Data on file. ISDIN Corp. 2024. Morristown, NJ.